New Delhi, India – April 23, 2013 – PharmaSecure has surpassed 500 million codes, which protect consumers from spurious medicines.
PharmaSecure’s unique coding technology allows the company to generate thousands of codes and print them in fast-paced manufacturing environments. These codes can then be verified at consumer, vender, or shipping levels.
This milestone coincides with new partnerships with three additional pharmaceutical companies, Dr. Reddy’s Lab, Strides Arcolabs and Ajanta Pharma. Long-time partner Lupin Pharmaceutical Ltd. was the lucky recipient of the 500 millionth code. PharmaSecure additionally works with top-ten pharma manufacturers across India and will be operational in Nigeria in coming months.
Today PharmaSecure protects medicines which are used for acute and chronic diseases such as diabetes and hypertension, among others.
The company’s codes are especially valuable to manufacturers as they discover how serialization connects millions of patients to mobile health services that can be provided directly from the manufacturer or through other health service providers.
PharmaSecure’s 500 million code milestone indicates a high acceptance of the company’s technology and growth into a robust mobile health framework.